Development of a Dual-Cross-Linked Collagen-Based Bioink for High-Resolution 3D Bioprinting and Antiaging
Biomacromolecules · 2026
DOI: 10.1021/acs.biomac.5c01416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Caihong Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China. Hauptthemen laut MEDLINE: Bioprinting, Printing, Three-Dimensional, Collagen, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China.
- Gansu Engineering Research Center of Medical Collagen, Lanzhou 730000, P. R. China.
- School of life science, Lanzhou University, Lanzhou 730000, P. R. China.
ORCID-Profile: Caihong Fu, Huixia He, Jianxi Xiao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fu, C., Fan, Y., Wang, J., Yang, Y., Liu, G., He, H., & Xiao, J. (2026). Development of a Dual-Cross-Linked Collagen-Based Bioink for High-Resolution 3D Bioprinting and Antiaging. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c01416
Vancouver
Fu C, Fan Y, Wang J, Yang Y, Liu G, He H, et al. Development of a Dual-Cross-Linked Collagen-Based Bioink for High-Resolution 3D Bioprinting and Antiaging. Biomacromolecules. 2026. doi:10.1021/acs.biomac.5c01416
BibTeX
@article{Fu2026,
author = {Fu, Caihong and Fan, Yirui and Wang, Jing and Yang, Yi and Liu, Guangyu and He, Huixia and Xiao, Jianxi},
title = {Development of a Dual-Cross-Linked Collagen-Based Bioink for High-Resolution 3D Bioprinting and Antiaging},
journal = {Biomacromolecules},
year = {2026},
doi = {10.1021/acs.biomac.5c01416}
}
EUVIMED